Shattuck Labs (STTK) Retained Earnings (2019 - 2026)
Shattuck Labs (STTK) posted quarterly Retained Earnings of -$445.3 million for Q1 2026, down 12.62% year-over-year from -$509.6 million in Q1 2025, and down 3.43% quarter-over-quarter from -$430.5 million in Q4 2025.
Shattuck Labs (STTK) Retained Earnings (2019 - 2026) Analysis & Trends
Shattuck Labs (STTK) has reported Retained Earnings for 8 consecutive years, with -$445.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Retained Earnings fell 12.62% year-over-year to -$445.3 million; the TTM figure through Mar 2026 stood at -$445.3 million (down 12.62% YoY), while the FY2025 annual figure was -$430.5 million, down 12.79% from the prior year.
- Retained Earnings declined to -$445.3 million in Q1 2026 per STTK's latest filing, from -$430.5 million in the prior quarter.
- Across five years, Retained Earnings topped out at $457.0 million in Q2 2024 and bottomed at -$445.3 million in Q1 2026.
- Historically, Retained Earnings has averaged -$99.5 million across 5 years, with a median of -$193.6 million in 2022.
- On a YoY basis, Retained Earnings climbed as much as 617643.24% in 2024 and fell as far as 5186400.0% in 2024.
- Shattuck Labs' Retained Earnings stood at -$877000.0 in 2022, then soared by 51526.0% to $451.0 million in 2023, then slumped by 184.64% to -$381.7 million in 2024, then declined by 12.79% to -$430.5 million in 2025, then retreated by 3.43% to -$445.3 million in 2026.
- Business Quant data shows STTK's Retained Earnings at -$445.3 million in Q1 2026, -$430.5 million in Q4 2025, and -$417.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -4.00 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.05 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -104.13 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 4.38 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -6.33 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.57 Bn |
| 10 | Shattuck Labs | 962.96 Mn | 962.96 Mn | - | 671.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 671.64 Mn |
| Mar 31, 2026 | -445.30 Mn |
| Dec 31, 2025 | -430.53 Mn |
| Sep 30, 2025 | -417.94 Mn |
| Jun 30, 2025 | -407.88 Mn |
| Mar 31, 2025 | -395.40 Mn |
| Dec 31, 2024 | -381.72 Mn |
| Sep 30, 2024 | -363.04 Mn |
| Jun 30, 2024 | 456.98 Mn |
| Mar 31, 2024 | 453.64 Mn |
| Dec 31, 2023 | 451.01 Mn |
| Sep 30, 2023 | 7,000.00 |
| Jun 30, 2023 | -74,000.00 |
| Mar 31, 2023 | -239.70 Mn |
| Dec 31, 2022 | -877,000.00 |
| Sep 30, 2022 | -193.60 Mn |
| Jun 30, 2022 | -168.97 Mn |
| Mar 31, 2022 | 391.06 Mn |
| Dec 31, 2021 | -117.07 Mn |
| Sep 30, 2021 | -1.83 Mn |